A Look into Hepatitis C Treatment Options from a Clinical and Managed Care Perspective

Kimberly Westrich, MA, chief strategy officer of the National Pharmaceutical Council, discusses key agenda highlights that will be presented at the 2024 AMCP Nexus conference.

On this episode of Managed Care Cast, we're talking with the chief science officer of the Center for Innovation & Value Research about key insights from its Rare Disease project.

Three patients with RPE65-related retinopathy showed improved function in both eyes following gene augmentation therapy treatment with voretigene neparvovec.

September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In our final episode, we speak with Lyndra Bills, MD, and Shari Hutchison, MS.

Two posters presented at the CHEST 2024 annual meeting show that although inhaled treprostinil reduces hospitalizations in patients with pulmonary hypertension due to interstitial lung disease (PH-ILD), real-world data suggest a higher rate of serious adverse events than previously reported in clinical trials.

Study findings reveals a 1-way relationship between cardiovascular disease and psoriasis, with no impact on other immune-mediated inflammatory diseases.